The settling of three particles in a narrow channel is simulated via the lattice Boltzmann direct-forcing/fictitious domain (LB-DF/FD) method for the Reynolds number ranging from 5 to 200. The effects of the wall and the Reynolds number are studied. It is interesting to find that at certain Reynolds numbers the left (right) particle is settling at 0.175 (0.825) of the channel width irrespective of its initial position or the channel width. Moreover, numerical results have shown that the lateral particles lead at small Reynolds numbers, while the central particle leads at large Reynolds numbers due to the combined effects of particle-particle and particle-wall interactions. The central particle will leave the lateral ones behind when the Reynolds number is large enough. Finally the effect of the Reynolds number on the trajectory of the lateral particles is presented.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2mLLZc1
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Me...
-
Abstract Desmoplastic small round cell tumor (DSCRT) is a rare malignancy most often seen in the abdomen or pelvis of young men. Unfortuna...
-
OBJECTIVE: Individual susceptibility to sepsis has received increasing attention in recent years, and the study of genetic variations has b...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nGQ2DC via IFTTT
-
Article content meets expectations Minimal relevance to assigned subject matter. Article content fails to meet all requirements Not Rubric f...
-
Objective To determine the association between neuroendocrine tumor (NET) biomarker levels and the extent of disease as assessed by 68 Ga DO...
-
by Mindaugas Paužuolis, Torsten Eich, Joachim Burman Background Natalizumab (NTZ) is a drug that has been widely used in the treatment of m...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου